Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch) Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch) conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch) Clinical research trials and Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch) healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch). Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch) Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch) clinical trial. Human subjects often receive the most effective healthcare possible for their Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch) condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.

Home > "B" Clinical Trials Conditions > Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)

Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)



Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)

For Condition: Alcoholism,Smoking
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: This study will develop a behavioral and drug relapse prevention program for individuals who are dependent on both alcohol and tobacco. The study's goal is to show that individuals receiving nicotine replacement therapy and naltrexone (Revia) with behavior therapy will have higher rates of abstinence from both smoking and drinking than individuals who do not receive the drug therapies. Individuals will be placed in a 12-week outpatient treatment program with followup assessments 1, 3, and 6 months after treatment.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/50 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Meets criteria for alcohol and nicotine dependence. - Individuals will be outpatients with alcohol and nicotine dependence who have completed detoxification (medicated or nonmedicated) within the past 48-120 hours. - Smoking no less than 10 cigarettes/day and no greater than 50 cigarettes/day. - Motivated to quit smoking. - Willing and able to participate in the 12 week outpatient treatment. - Acceptable health. - Able to provide a collateral informant. - Willing to be followed for 6 months after treatment ends. - Willing and able to provide the names of three family members or friends to aid in locating participants for follow-up. Exclusion Criteria: - Current diagnosis of dependence on other substances except nicotine and alcohol. - Having moderately severe or severe alcohol withdrawal symptoms. - Recent (less than 48 hours) evidence of hazardous drinking (more than 2 drinks/day for females; 3 drinks/day for males). - History of opioid abuse. - Recent use of cocaine. - Not desiring to quit smoking. - Recent past or current pharmacotherapy involving naltrexone or transdermal nicotine systems. - History of psychosis. - Current suicidality, homicidally or psychiatric symptoms requiring other medications. - Presence of medical abnormalities that contraindicate naltrexone or nicotine replacement therapy. - Current treatment with psychotropic medications. - Pregnancy or nursing for female patients. Inability or unwillingness to participate in the 12-week outpatient treatment.
Total Enrollment: 200

Location and Contact Information:

Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center *Recruiting*
Houston,  Texas,  77030
United States
Recruiting Dr.  Schmitz 713-500-2874


Additional Information:
Study ID Numbers:
  NIAAASCH11216; 
Study Start Date: 
Record last reviewed: March 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000447

Other Alcoholism Studies:
1. Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal

2. Naltrexone for Early Problem Drinkers

3. Pharmacological Intervention Project (fluoxetine)

4. Naltrexone Treatment for Alcoholic Women

5. Pharmacologic Relapse Prevention for Alcoholic Smokers

Related Studies:

Other Alcoholism Clinical Trials
Other Texas Clinical Trials
Other Houston Clinical Trials

Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)

Modify your Search

  Other Alcoholism Clinical Trials
  Other Texas Clinical Trials
  Other Houston Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103